Human immune proteome in experimental colonization with Staphylococcus aureus

Clinical and Vaccine Immunology

Volumn 16, Issue 11, 2009, Pages 1607-1614

  Holtfreter, Silva ^a   Nguyen, Thi Thu Hoai ^a   Wertheim, Heiman ^b,c   Steil, Leif ^a   Kusch, Harald ^a   Truong, Quoc Phong ^a   Engelmann, Susanne ^a   Hecker, Michael ^a   Völker, Uwe ^a   Van Belkum, Alex ^b   Bröker, Barbara M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; BACTERIAL PROTEIN; BETA HEMOLYSIN; CYSTEINE PROTEINASE; HEMOLYSIN; IMMUNOGLOBULIN G; PHOSPHOLIPASE C; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; HUMAN; HUMORAL IMMUNITY; IMMUNOBLOTTING; NORMAL HUMAN; NOSE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ADULT; ANTIBODIES, BACTERIAL; CARRIER STATE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MALE; PROTEOME; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 70350702940     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00263-09     Document Type: Article

References (38)

1. Acton, D. S., M. J. Plat-Sinnige, W. van Wamel, N. de Groot, and A. van Belkum. 2009. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact? Eur. J. Clin. Microbiol. Infect. Dis. 28:115-127.
2. Boucher, H. W., and G. R. Corey. 2008. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 46:S344-S349.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Burlak, C., C. H. Hammer, M. A. Robinson, A. R. Whitney, M. J. McGavin, B. N. Kreiswirth, and F. R. Deleo. 2007. Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell. Microbiol. 9:1172-1190.
5. Colque-Navarro, P., B. Soderquist, H. Holmberg, L. Blomqvist, P. Olcen, and R. Mollby. 1998. Antibody response in Staphylococcus aureus septicaemia - a prospective study. J. Med. Microbiol. 47:217-225.
6. Dryla, A., S. Prustomersky, D. Gelbmann, M. Hanner, E. Bettinger, B. Kocsis, T. Kustos, T. Henics, A. Meinke, and E. Nagy. 2005. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab. Immunol. 12:387-398.
7. Etz, H., D. Minh, T. Henics, A. Dryla, B. Winkler, C. Triska, A. Boyd, J. Söllner, W. Schmidt, U. von Ahsen, M. Buschle, S. Gill, J. Kolonay, H. Khalak, C. Fraser, A. von Gabain, E. Nagy, and A. Meinke. 2002. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 99:6573-6578.
8. Foster, T. J. 2004. The Staphylococcus aureus "superbug." J. Clin. Investig. 114:1693-1696.
9. Goerke, C., and C. Wolz. 2004. Regulatory and genomic plasticity of Staphylococcus aureus during persistent colonization and infection. Int. J. Med. Microbiol. 294:195-202.
10. Hancock, K., and V. C. Tsang. 1983. India ink staining of proteins on nitrocellulose paper. Anal. Biochem. 133:157-162.
11. Holtfreter, S., K. Bauer, D. Thomas, C. Feig, V. Lorenz, K. Roschack, E. Friebe, K. Selleng, S. Lovenich, T. Greve, A. Greinacher, B. Panzig, S. Engelmann, G. Lina, and B. M. Bröker. 2004. egc-encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect. Immun. 72:4061-4071.
12. Holtfreter, S., K. Roschack, P. Eichler, K. Eske, B. Holtfreter, C. Kohler, S. Engelmann, M. Hecker, A. Greinacher, and B. M. Bröker. 2006. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J. Infect. Dis. 193:1275-1278.
13. Josefsson, E., O. Hartford, L. O'Brien, J. M. Patti, and T. Foster. 2001. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J. Infect. Dis. 184:1572-1580.
14. Kanclerski, K., B. Soderquist, M. Kjellgren, H. Holmberg, and R. Mollby. 1996. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia. J. Med. Microbiol. 44:171-177.
15. Lindsay, J. A., and M. T. Holden. 2006. Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus. Funct. Integr. Genomics 6:186-201.
16. McKenney, D., K. L. Pouliot, Y. Wang, V. Murthy, M. Ulrich, G. Döring, J. C. Lee, D. A. Goldmann, and G. B. Pier. 1999. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 284:1523-1527.
17. Mertz, D., R. Frei, B. Jaussi, A. Tietz, C. Stebler, U. Fluckiger, and A. F. Widmer. 2007. Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. Clin. Infect. Dis. 45:475-477.
18. Nouwen, J., H. Boelens, A. van Belkum, and H. Verbrugh. 2004. Human factor in Staphylococcus aureus nasal carriage. Infect. Immun. 72:6685-6688.
19. Reference deleted.
20. Novick, R. 1967. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33:155-166.
21. Patel, A., P. Nowlan, E. Weavers, and T. Foster. 1987. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55:3103-3110.
22. Rennermalm, A., Y. H. Li, L. Bohaufs, C. Jarstrand, A. Brauner, F. R. Brennan, and J. I. Flock. 2001. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 19:3376-3383.
23. Rogasch, K., V. Rühmling, J. Pané-Farré, D. Höper, C. Weinberg, S. Fuchs, M. Schmudde, B. M. Bröker, C. Wolz, M. Hecker, and S. Engelmann. 2006. The influence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strains. J. Bacteriol. 188:7742-7758.
24. Schaffer, A. C., and J. C. Lee. 2008. Vaccination and passive immunisation against Staphylococcus aureus. Int. J. Antimicrob. Agents 32(Suppl. 1):S71-S78.
25. Schaffer, A. C., R. M. Solinga, J. Cocchiaro, M. Portoles, K. B. Kiser, A. Risley, S. M. Randall, V. Valtulina, P. Speziale, E. Walsh, T. Foster, and J. C. Lee. 2006. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect. Immun. 74:2145-2153.
26. Schlievert, P. 2001. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J. Allergy Clin. Immunol. 108:S107-S110.
27. Stolz, S. J., J. P. Davis, J. M. Vergeront, B. A. Crass, P. J. Chesney, P. J. Wand, and M. S. Bergdoll. 1985. Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J. Infect. Dis. 151:883-889.
28. van Belkum, A. 2006. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence. Curr. Opin. Infect. Dis. 19:339-344.
29. van Belkum, A., N. J. Verkaik, C. P. de Vogel, H. A. Boelens, J. Verveer, J. L. Nouwen, H. A. Verbrugh, and H. F. Wertheim. 2009. Reclassification of Staphylococcus aureus nasal carriage types. J. Infect. Dis. 199:1820-1826.
30. VandenBergh, M. F. Q., E. P. F. Yzerman, A. van Belkum, H. A. M. Boelens, M. Sijmons, and H. A. Verbrugh. 1999. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J. Clin. Microbiol. 37:3133-3140.
31. Verkaik, N. J., C. P. de Vogel, H. A. Boelens, D. Grumann, T. Hoogenboezem, C. Vink, H. Hooijkaas, T. J. Foster, H. A. Verbrugh, A. van Belkum, and W. J. van Wamel. 2009. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J. Infect. Dis. 199:625-632.
32. von Eiff, C., K. Becker, K. Machka, H. Stammer, and G. Peters. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
33. Wardenburg, J. B., and O. Schneewind. 2008. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205:287-294.
34. Wertheim, H. F., D. C. Melles, M. C. Vos, W. van Leeuwen, A. van Belkum, H. A. Verbrugh, and J. L. Nouwen. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5:751-762.
35. Wertheim, H. F., M. C. Vos, A. Ott, A. van Belkum, A. Voss, J. A. Kluytmans, P. H. van Keulen, C. M. Vandenbroucke-Grauls, M. H. Meester, and H. A. Verbrugh. 2004. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364:703-705.
36. Wertheim, H. F., E. Walsh, R. Choudhurry, D. C. Melles, H. A. Boelens, H. Miajlovic, H. A. Verbrugh, T. Foster, and A. van Belkum. 2008. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med. 5:e17.
37. B in growth phase dependent regulation of virulence factors in Staphylococcus aureus. Proteomics 4:3034-3047.
38. B. Proteomics 1:480-493.